Global Rare Disease Drug Market Outlook 2021

Table of Contents
1 Rare Disease Drug Market Overview
1.1 Product Overview and Scope of Rare Disease Drug
1.2 Rare Disease Drug Segment by Type
1.2.1 Global Rare Disease Drug Sales Growth Rate Comparison by Type (2020-2026)
1.2.2 Above 1‰
1.2.3 0.65‰~1‰
1.2.4 Below 0.1‰
1.3 Rare Disease Drug Segment by Application
1.3.1 Rare Disease Drug Sales Comparison by Application: (2020-2026)
1.3.2 Hospital Pharmacies
1.3.3 Speciality Pharmacies
1.3.4 Retail pharmacies
1.3.5 Others
1.4 Global Rare Disease Drug Market Size Estimates and Forecasts
1.4.1 Global Rare Disease Drug Revenue 2015-2026
1.4.2 Global Rare Disease Drug Sales 2015-2026
1.4.3 Rare Disease Drug Market Size by Region: 2020 Versus 2026

2 Global Rare Disease Drug Market Competition by Manufacturers
2.1 Global Rare Disease Drug Sales Market Share by Manufacturers (2015-2020)
2.2 Global Rare Disease Drug Revenue Share by Manufacturers (2015-2020)
2.3 Global Rare Disease Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Rare Disease Drug Manufacturing Sites, Area Served, Product Type
2.5 Rare Disease Drug Market Competitive Situation and Trends
2.5.1 Rare Disease Drug Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Rare Disease Drug Players (Opinion Leaders)

3 Rare Disease Drug Retrospective Market Scenario by Region
3.1 Global Rare Disease Drug Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Rare Disease Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Rare Disease Drug Market Facts & Figures by Country
3.3.1 North America Rare Disease Drug Sales by Country
3.3.2 North America Rare Disease Drug Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Rare Disease Drug Market Facts & Figures by Country
3.4.1 Europe Rare Disease Drug Sales by Country
3.4.2 Europe Rare Disease Drug Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Rare Disease Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Rare Disease Drug Sales by Region
3.5.2 Asia Pacific Rare Disease Drug Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Rare Disease Drug Market Facts & Figures by Country
3.6.1 Latin America Rare Disease Drug Sales by Country
3.6.2 Latin America Rare Disease Drug Sales by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Rare Disease Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Rare Disease Drug Sales by Country
3.7.2 Middle East and Africa Rare Disease Drug Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Rare Disease Drug Historic Market Analysis by Type
4.1 Global Rare Disease Drug Sales Market Share by Type (2015-2020)
4.2 Global Rare Disease Drug Revenue Market Share by Type (2015-2020)
4.3 Global Rare Disease Drug Price Market Share by Type (2015-2020)
4.4 Global Rare Disease Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Rare Disease Drug Historic Market Analysis by Application
5.1 Global Rare Disease Drug Sales Market Share by Application (2015-2020)
5.2 Global Rare Disease Drug Revenue Market Share by Application (2015-2020)
5.3 Global Rare Disease Drug Price by Application (2015-2020)

6 Company Profiles and Key Figures in Rare Disease Drug Business
6.1 Novartis AG
6.1.1 Corporation Information
6.1.2 Novartis AG Description, Business Overview
6.1.3 Novartis AG Rare Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Novartis AG Products Offered
6.1.5 Novartis AG Recent Development
6.2 Bristol-Myers Squibb Company
6.2.1 Bristol-Myers Squibb Company Corporation Information
6.2.2 Bristol-Myers Squibb Company Description, Business Overview
6.2.3 Bristol-Myers Squibb Company Rare Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Bristol-Myers Squibb Company Products Offered
6.2.5 Bristol-Myers Squibb Company Recent Development
6.3 Celgene Corporation
6.3.1 Celgene Corporation Corporation Information
6.3.2 Celgene Corporation Description, Business Overview
6.3.3 Celgene Corporation Rare Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Celgene Corporation Products Offered
6.3.5 Celgene Corporation Recent Development
6.4 F. Hoffmann-La Roche Ltd.
6.4.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.4.2 F. Hoffmann-La Roche Ltd. Description, Business Overview
6.4.3 F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 F. Hoffmann-La Roche Ltd. Products Offered
6.4.5 F. Hoffmann-La Roche Ltd. Recent Development
6.5 Pfizer, Inc.
6.5.1 Pfizer, Inc. Corporation Information
6.5.2 Pfizer, Inc. Description, Business Overview
6.5.3 Pfizer, Inc. Rare Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Pfizer, Inc. Products Offered
6.5.5 Pfizer, Inc. Recent Development
6.6 Sanofi S.A.
6.6.1 Sanofi S.A. Corporation Information
6.6.2 Sanofi S.A. Description, Business Overview
6.6.3 Sanofi S.A. Rare Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Sanofi S.A. Products Offered
6.6.5 Sanofi S.A. Recent Development
6.7 Alexion Pharmaceuticals, Inc.
6.6.1 Alexion Pharmaceuticals, Inc. Corporation Information
6.6.2 Alexion Pharmaceuticals, Inc. Description, Business Overview
6.6.3 Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Alexion Pharmaceuticals, Inc. Products Offered
6.7.5 Alexion Pharmaceuticals, Inc. Recent Development
6.8 Eli Lilly and Company
6.8.1 Eli Lilly and Company Corporation Information
6.8.2 Eli Lilly and Company Description, Business Overview
6.8.3 Eli Lilly and Company Rare Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Eli Lilly and Company Products Offered
6.8.5 Eli Lilly and Company Recent Development
6.9 Novo Nordisk A/S
6.9.1 Novo Nordisk A/S Corporation Information
6.9.2 Novo Nordisk A/S Description, Business Overview
6.9.3 Novo Nordisk A/S Rare Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Novo Nordisk A/S Products Offered
6.9.5 Novo Nordisk A/S Recent Development
6.10 AstraZeneca
6.10.1 AstraZeneca Corporation Information
6.10.2 AstraZeneca Description, Business Overview
6.10.3 AstraZeneca Rare Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.10.4 AstraZeneca Products Offered
6.10.5 AstraZeneca Recent Development
6.11 Eisai Co., Ltd.
6.11.1 Eisai Co., Ltd. Corporation Information
6.11.2 Eisai Co., Ltd. Rare Disease Drug Description, Business Overview
6.11.3 Eisai Co., Ltd. Rare Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Eisai Co., Ltd. Products Offered
6.11.5 Eisai Co., Ltd. Recent Development
6.12 Daiichi Sankyo Company Limited
6.12.1 Daiichi Sankyo Company Limited Corporation Information
6.12.2 Daiichi Sankyo Company Limited Rare Disease Drug Description, Business Overview
6.12.3 Daiichi Sankyo Company Limited Rare Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Daiichi Sankyo Company Limited Products Offered
6.12.5 Daiichi Sankyo Company Limited Recent Development
6.13 Bayer AG
6.13.1 Bayer AG Corporation Information
6.13.2 Bayer AG Rare Disease Drug Description, Business Overview
6.13.3 Bayer AG Rare Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Bayer AG Products Offered
6.13.5 Bayer AG Recent Development
6.14 GlaxoSmithKline
6.14.1 GlaxoSmithKline Corporation Information
6.14.2 GlaxoSmithKline Rare Disease Drug Description, Business Overview
6.14.3 GlaxoSmithKline Rare Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.14.4 GlaxoSmithKline Products Offered
6.14.5 GlaxoSmithKline Recent Development
6.15 Merck & Co., Inc.
6.15.1 Merck & Co., Inc. Corporation Information
6.15.2 Merck & Co., Inc. Rare Disease Drug Description, Business Overview
6.15.3 Merck & Co., Inc. Rare Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Merck & Co., Inc. Products Offered
6.15.5 Merck & Co., Inc. Recent Development
6.16 Johnson & Johnson
6.16.1 Johnson & Johnson Corporation Information
6.16.2 Johnson & Johnson Rare Disease Drug Description, Business Overview
6.16.3 Johnson & Johnson Rare Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Johnson & Johnson Products Offered
6.16.5 Johnson & Johnson Recent Development
6.17 Biogen, Inc.
6.17.1 Biogen, Inc. Corporation Information
6.17.2 Biogen, Inc. Rare Disease Drug Description, Business Overview
6.17.3 Biogen, Inc. Rare Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Biogen, Inc. Products Offered
6.17.5 Biogen, Inc. Recent Development
6.18 Takeda
6.18.1 Takeda Corporation Information
6.18.2 Takeda Rare Disease Drug Description, Business Overview
6.18.3 Takeda Rare Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.18.4 Takeda Products Offered
6.18.5 Takeda Recent Development
6.19 Amgen, Inc.
6.19.1 Amgen, Inc. Corporation Information
6.19.2 Amgen, Inc. Rare Disease Drug Description, Business Overview
6.19.3 Amgen, Inc. Rare Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.19.4 Amgen, Inc. Products Offered
6.19.5 Amgen, Inc. Recent Development
6.20 Deciphera
6.20.1 Deciphera Corporation Information
6.20.2 Deciphera Rare Disease Drug Description, Business Overview
6.20.3 Deciphera Rare Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.20.4 Deciphera Products Offered
6.20.5 Deciphera Recent Development
6.21 Atara Biotherapeutics
6.21.1 Atara Biotherapeutics Corporation Information
6.21.2 Atara Biotherapeutics Rare Disease Drug Description, Business Overview
6.21.3 Atara Biotherapeutics Rare Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.21.4 Atara Biotherapeutics Products Offered
6.21.5 Atara Biotherapeutics Recent Development
6.22 ProQR
6.22.1 ProQR Corporation Information
6.22.2 ProQR Rare Disease Drug Description, Business Overview
6.22.3 ProQR Rare Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.22.4 ProQR Products Offered
6.22.5 ProQR Recent Development

7 Rare Disease Drug Manufacturing Cost Analysis
7.1 Rare Disease Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Rare Disease Drug
7.4 Rare Disease Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Rare Disease Drug Distributors List
8.3 Rare Disease Drug Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Rare Disease Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Rare Disease Drug by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Rare Disease Drug by Type (2021-2026)
10.2 Rare Disease Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Rare Disease Drug by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Rare Disease Drug by Application (2021-2026)
10.3 Rare Disease Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Rare Disease Drug by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Rare Disease Drug by Region (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables
Table 1. Global Rare Disease Drug Sales (K Doses) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Rare Disease Drug Sales (K Doses) Comparison by Application: 2020 VS 2026
Table 3. Global Rare Disease Drug Market Size by Type (K Doses) (US$ Million) (2020 VS 2026)
Table 4. Global Key Rare Disease Drug Manufacturers Covered in This Study
Table 5. Global Rare Disease Drug Sales (K Doses) by Manufacturers (2015-2020)
Table 6. Global Rare Disease Drug Sales Share by Manufacturers (2015-2020)
Table 7. Global Rare Disease Drug Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Rare Disease Drug Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Rare Disease Drug Average Price (USD/Dose) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Rare Disease Drug Sales Sites and Area Served
Table 11. Manufacturers Rare Disease Drug Product Types
Table 12. Global Rare Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Rare Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Disease Drug as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Rare Disease Drug Players
Table 16. Global Rare Disease Drug Sales (K Doses) by Region (2015-2020)
Table 17. Global Rare Disease Drug Sales Market Share by Region (2015-2020)
Table 18. Global Rare Disease Drug Revenue (Million US$) by Region (2015-2020)
Table 19. Global Rare Disease Drug Revenue Market Share by Region (2015-2020)
Table 20. North America Rare Disease Drug Sales by Country (2015-2020) (K Doses)
Table 21. North America Rare Disease Drug Sales Market Share by Country (2015-2020)
Table 22. North America Rare Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Rare Disease Drug Revenue Market Share by Country (2015-2020)
Table 24. Europe Rare Disease Drug Sales by Country (2015-2020) (K Doses)
Table 25. Europe Rare Disease Drug Sales Market Share by Country (2015-2020)
Table 26. Europe Rare Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Rare Disease Drug Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Rare Disease Drug Sales by Region (2015-2020) (K Doses)
Table 29. Asia Pacific Rare Disease Drug Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Rare Disease Drug Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Rare Disease Drug Revenue Market Share by Region (2015-2020)
Table 32. Latin America Rare Disease Drug Sales by Country (2015-2020) (K Doses)
Table 33. Latin America Rare Disease Drug Sales Market Share by Country (2015-2020)
Table 34. Latin America Rare Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Rare Disease Drug Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Rare Disease Drug Sales by Country (2015-2020) (K Doses)
Table 37. Middle East and Africa Rare Disease Drug Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Rare Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Rare Disease Drug Revenue Market Share by Country (2015-2020)
Table 40. Global Rare Disease Drug Sales (K Doses) by Type (2015-2020)
Table 41. Global Rare Disease Drug Sales Share by Type (2015-2020)
Table 42. Global Rare Disease Drug Revenue (Million US$) by Type (2015-2020)
Table 43. Global Rare Disease Drug Revenue Share by Type (2015-2020)
Table 44. Global Rare Disease Drug Price (USD/Dose) by Type (2015-2020)
Table 45. Global Rare Disease Drug Sales (K Doses) by Application (2015-2020)
Table 46. Global Rare Disease Drug Sales Market Share by Application (2015-2020)
Table 47. Global Rare Disease Drug Sales Growth Rate by Application (2015-2020)
Table 48. Novartis AG Corporation Information
Table 49. Novartis AG Description and Business Overview
Table 50. Novartis AG Rare Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 51. Novartis AG Main Product
Table 52. Novartis AG Recent Development
Table 53. Bristol-Myers Squibb Company Corporation Information
Table 54. Bristol-Myers Squibb Company Description and Business Overview
Table 55. Bristol-Myers Squibb Company Rare Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 56. Bristol-Myers Squibb Company Main Product
Table 57. Bristol-Myers Squibb Company Recent Development
Table 58. Celgene Corporation Corporation Information
Table 59. Celgene Corporation Description and Business Overview
Table 60. Celgene Corporation Rare Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 61. Celgene Corporation Main Product
Table 62. Celgene Corporation Recent Development
Table 63. F. Hoffmann-La Roche Ltd. Corporation Information
Table 64. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 65. F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 66. F. Hoffmann-La Roche Ltd. Main Product
Table 67. F. Hoffmann-La Roche Ltd. Recent Development
Table 68. Pfizer, Inc. Corporation Information
Table 69. Pfizer, Inc. Description and Business Overview
Table 70. Pfizer, Inc. Rare Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 71. Pfizer, Inc. Main Product
Table 72. Pfizer, Inc. Recent Development
Table 73. Sanofi S.A. Corporation Information
Table 74. Sanofi S.A. Description and Business Overview
Table 75. Sanofi S.A. Rare Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 76. Sanofi S.A. Main Product
Table 77. Sanofi S.A. Recent Development
Table 78. Alexion Pharmaceuticals, Inc. Corporation Information
Table 79. Alexion Pharmaceuticals, Inc. Description and Business Overview
Table 80. Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 81. Alexion Pharmaceuticals, Inc. Main Product
Table 82. Alexion Pharmaceuticals, Inc. Recent Development
Table 83. Eli Lilly and Company Corporation Information
Table 84. Eli Lilly and Company Description and Business Overview
Table 85. Eli Lilly and Company Rare Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 86. Eli Lilly and Company Main Product
Table 87. Eli Lilly and Company Recent Development
Table 88. Novo Nordisk A/S Corporation Information
Table 89. Novo Nordisk A/S Description and Business Overview
Table 90. Novo Nordisk A/S Rare Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 91. Novo Nordisk A/S Main Product
Table 92. Novo Nordisk A/S Recent Development
Table 93. AstraZeneca Corporation Information
Table 94. AstraZeneca Description and Business Overview
Table 95. AstraZeneca Rare Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 96. AstraZeneca Main Product
Table 97. AstraZeneca Recent Development
Table 98. Eisai Co., Ltd. Corporation Information
Table 99. Eisai Co., Ltd. Description and Business Overview
Table 100. Eisai Co., Ltd. Rare Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 101. Eisai Co., Ltd. Main Product
Table 102. Eisai Co., Ltd. Recent Development
Table 103. Daiichi Sankyo Company Limited Corporation Information
Table 104. Daiichi Sankyo Company Limited Description and Business Overview
Table 105. Daiichi Sankyo Company Limited Rare Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 106. Daiichi Sankyo Company Limited Main Product
Table 107. Daiichi Sankyo Company Limited Recent Development
Table 108. Bayer AG Corporation Information
Table 109. Bayer AG Description and Business Overview
Table 110. Bayer AG Rare Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 111. Bayer AG Main Product
Table 112. Bayer AG Recent Development
Table 113. GlaxoSmithKline Corporation Information
Table 114. GlaxoSmithKline Description and Business Overview
Table 115. GlaxoSmithKline Rare Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 116. GlaxoSmithKline Main Product
Table 117. GlaxoSmithKline Recent Development
Table 118. Merck & Co., Inc. Corporation Information
Table 119. Merck & Co., Inc. Description and Business Overview
Table 120. Merck & Co., Inc. Rare Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 121. Merck & Co., Inc. Main Product
Table 122. Merck & Co., Inc. Recent Development
Table 123. Johnson & Johnson Corporation Information
Table 124. Johnson & Johnson Description and Business Overview
Table 125. Johnson & Johnson Rare Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 126. Johnson & Johnson Main Product
Table 127. Johnson & Johnson Recent Development
Table 128. Biogen, Inc. Corporation Information
Table 129. Biogen, Inc. Description and Business Overview
Table 130. Biogen, Inc. Rare Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 131. Biogen, Inc. Main Product
Table 132. Biogen, Inc. Recent Development
Table 133. Takeda Corporation Information
Table 134. Takeda Description and Business Overview
Table 135. Takeda Rare Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 136. Takeda Main Product
Table 137. Takeda Recent Development
Table 138. Amgen, Inc. Corporation Information
Table 139. Amgen, Inc. Description and Business Overview
Table 140. Amgen, Inc. Rare Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 141. Amgen, Inc. Main Product
Table 142. Amgen, Inc. Recent Development
Table 143. Deciphera Corporation Information
Table 144. Deciphera Description and Business Overview
Table 145. Deciphera Rare Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 146. Deciphera Main Product
Table 147. Deciphera Recent Development
Table 148. Atara Biotherapeutics Corporation Information
Table 149. Atara Biotherapeutics Description and Business Overview
Table 150. Atara Biotherapeutics Rare Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 151. Atara Biotherapeutics Main Product
Table 152. Atara Biotherapeutics Recent Development
Table 153. ProQR Corporation Information
Table 154. ProQR Description and Business Overview
Table 155. ProQR Rare Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 156. ProQR Main Product
Table 157. ProQR Recent Development
Table 158. Production Base and Market Concentration Rate of Raw Material
Table 159. Key Suppliers of Raw Materials
Table 160. Rare Disease Drug Distributors List
Table 161. Rare Disease Drug Customers List
Table 162. Rare Disease Drug Market Trends
Table 163. Rare Disease Drug Opportunities and Drivers
Table 164. Rare Disease Drug Market Challenges
Table 165. Global Rare Disease Drug Sales (K Doses) Forecast by Type (2021-2026)
Table 166. Global Rare Disease Drug Sales Market Share Forecast by Type (2021-2026)
Table 167. Global Rare Disease Drug Revenue (Million US$) Forecast by Type (2021-2026)
Table 168. Global Rare Disease Drug Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 169. Global Rare Disease Drug Sales (K Doses) Forecast by Application (2021-2026)
Table 170. Global Rare Disease Drug Revenue (Million US$) Forecast by Application (2021-2026)
Table 171. Global Rare Disease Drug Sales (K Doses) Forecast by Region (2021-2026)
Table 172. Global Rare Disease Drug Sales Market Share Forecast by Region (2021-2026)
Table 173. Global Rare Disease Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 174. Global Rare Disease Drug Revenue Market Share Forecast by Region (2021-2026)
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Rare Disease Drug
Figure 2. Global Rare Disease Drug Sales Market Share by Type: 2020 VS 2026
Figure 3. Above 1‰ Product Picture
Figure 4. 0.65‰?1‰ Product Picture
Figure 5. Below 0.1‰ Product Picture
Figure 6. Global Rare Disease Drug Consumption Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacies
Figure 8. Speciality Pharmacies
Figure 9. Retail pharmacies
Figure 10. Others
Figure 11. Global Rare Disease Drug Market Size 2015-2026 (US$ Million)
Figure 12. Global Rare Disease Drug Sales Capacity (K Doses) (2015-2026)
Figure 13. Global Rare Disease Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Rare Disease Drug Sales Share by Manufacturers in 2020
Figure 15. Global Rare Disease Drug Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Rare Disease Drug Revenue in 2019
Figure 17. Rare Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Rare Disease Drug Sales Market Share by Region (2015-2020)
Figure 19. Global Rare Disease Drug Sales Market Share by Region in 2019
Figure 20. Global Rare Disease Drug Revenue Market Share by Region (2015-2020)
Figure 21. Global Rare Disease Drug Revenue Market Share by Region in 2019
Figure 22. North America Rare Disease Drug Sales Market Share by Country in 2019
Figure 23. North America Rare Disease Drug Revenue Market Share by Country in 2019
Figure 24. U.S. Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 25. U.S. Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 27. Canada Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Rare Disease Drug Sales Market Share by Country in 2019
Figure 29. Europe Rare Disease Drug Revenue Market Share by Country in 2019
Figure 30. Germany Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 31. Germany Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 33. France Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 35. U.K. Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 37. Italy Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 39. Russia Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Rare Disease Drug Sales Market Share by Region in 2019
Figure 41. Asia Pacific Rare Disease Drug Revenue Market Share by Region in 2019
Figure 42. China Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 43. China Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 45. Japan Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 47. South Korea Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 49. India Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Australia Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 53. Taiwan Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 55. Indonesia Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 57. Thailand Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 59. Malaysia Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 61. Philippines Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 63. Vietnam Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Rare Disease Drug Sales Market Share by Country in 2019
Figure 65. Latin America Rare Disease Drug Revenue Market Share by Country in 2019
Figure 66. Mexico Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 67. Mexico Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 69. Brazil Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 71. Argentina Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Rare Disease Drug Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Rare Disease Drug Revenue Market Share by Country in 2019
Figure 74. Turkey Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Turkey Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Saudi Arabia Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. U.A.E Rare Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 79. U.A.E Rare Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Rare Disease Drug by Type (2015-2020)
Figure 81. Sales Market Share of Rare Disease Drug by Type in 2020
Figure 82. Global Rare Disease Drug Market Share by Price Range (2015-2020)
Figure 83. Revenue Market Share of Rare Disease Drug by Type in 2019
Figure 84. Global Rare Disease Drug Sales Growth by Type (2015-2020) (K Doses)
Figure 85. Sales Market Share of Rare Disease Drug by Application (2015-2020)
Figure 86. Sales Market Share of Rare Disease Drug by Application in 2020
Figure 87. Revenue Share of Rare Disease Drug by Application (2015-2020)
Figure 88. Revenue Share of Rare Disease Drug by Application in 2020
Figure 89. Key Raw Materials Price Trend
Figure 90. Manufacturing Cost Structure of Rare Disease Drug
Figure 91. Manufacturing Process Analysis of Rare Dis